Skip to main content
. 2021 Dec 6;11:615. doi: 10.1038/s41398-021-01744-6

Table 2.

Post-treatment (T1) descriptive statistics and zero-order correlations.

Variable M SD 1 2 3 4 5 6 7 8 9
1. Depressive symptoms (BDI-II) 8.69 6.92
2. State anxiety (SAI) 35.00 8.47 0.74**
3. Perceived stress (PSS) 13.96 6.75 0.71** 0.74**
4. Negative affect (PANAS) 16.28 5.86 0.71** 0.75** 0.71**
5. Sleep disturbance (PSQI) 7.54 3.49 0.47** 0.31** 0.36** 0.33**
6. Childhood adversity (RF)a 27.83 10.44 0.27** 0.26** 0.23** 0.23** 0.05
7. Composite inflammatory index 0.53 2.22 0.16 0.13 0.08 0.01 0.14 0.19*
8. CRP (mg/L) 2.14 2.83 0.07 0.07 0.06 −0.05 0.12 −0.00 0.59**
9. IL-6 (pg/mL) 1.65 1.03 0.09 0.10 0.05 0.05 0.12 0.10 0.71** 0.46**
10. sTNF-RII (pg/mL) 2289.01 623.57 0.07 0.04 −0.01 −0.07 0.02 0.15 0.66** 0.08 0.18*

Note. M = mean; SD = standard deviation; *p < .05; **p < .01. BDI-II Beck Depression Inventory II; SAI State Anxiety Questionnaire; PSS Perceived Stress Scale; PANAS Positive Affect Negative Affect Scale; PSQI Pittsburg Sleep Quality Inventory; RF Risky Families questionnaire; CRP C-reactive Protein; IL-6 Interleukin 6; sTNF-RII soluble tumor necrosis factor receptor type II.

a All variables listed in this table were collected at T1, with the exception of the Risky Families questionnaire which was collected at T3.